Two well known and complimentary institutions have combined forces with the Qatar government to form the Qatar National Center for Rare Disease. Hamad Medical Corporation, established by Emiri decree in 1979, is Qatar’s premier not-for-profit health care provider. It manages eight hospitals as well as the national ambulance service and a home healthcare service. It is the only healthcare organization outside of the United States to receive simultaneous Joint Commission International (JCI) re-accreditation for all of its hospitals and in 2011 the ambulance service and home healthcare service also received JCI accreditation.
Heidelberg University Hospital is one of the leading medical centers in Europe. With its 43 specialized clinical departments, it cares for hundreds of thousands of patients from many countries.
The agreement for the new center was signed by Dr. Hanan Mohamed al-Kuwari, Minister of Public Health, and Professor Dr. Annette Gruters-Kieslich, chief medical director and chairperson of the board of Heidelberg University Hospital. Over the weekend, officials from HMC and the acclaimed German research institution, gathered for the Doha-Heidelberg Clinical, Oncology, Research Conference. The conference also saw the hosting of the first Rare Disease Symposium, illustrating the growing interest in this topic. “We signed an agreement last year to deepen the long-standing relationship between HMC and Heidelberg University Hospital and we have already seen significant benefits resulting from the close collaboration between both our institutions. During the past year, we held a neurosciences symposium to coincide with Multiple Sclerosis Day and Heidelberg University Hospital contributed numerous speakers to the programme for our 3rd Annual Breast Cancer Conference in October. A senior delegation from HMC’s Radiology Department also visited Heidelberg in May to explore potential areas of collaboration,” said Dr al-Kaabi